Prevention of Anaphylaxis Episodes in Idiopathic Anaphylaxis by Omalizumab.
Mitja KošnikLea ZuganMatija Rijavec
Published in: International archives of allergy and immunology (2024)
All patients in our study had complete responses to omalizumab. The presence of KIT p.D816V and HαT did not influence the response to omalizumab treatment.